The bottleneck to curing all diseases: incentives, trial institutions, or scientific advances?
Afinetheorem · x · 2026-08-12
Afinetheorem re-ups Saloni Dattani's article 'Cure all diseases' from Works in Progress, highlighting the surprising lack of awareness about medical progress and discussing the bottlenecks to faster innovation: improving incentives, establishing institutions for more rapid trials, and raw scientific advances. The author finds the topic exciting.
More from AGI Musings
- Are LLMs Killing CTFs? Security Research Faces a Skill Pipeline Crisis — evilsocket · 2026-08-12
- Musk Says AI Will Take Over Digital Jobs 'Like Lightning' — r0ck3t23 · 2026-08-12
- Elon Musk's View: Intelligence Has No Limit, Betting on AI is Inevitable — PTrubey · 2026-08-12
- 2027 Work Paradigm: Allocating Capital to Agent Threads and Handling Exceptions — curious_vii · 2026-08-12
- Indie Dev Insights: The Fatal Flaw of LLMs in Knowledge Management — StewartalsopIII · 2026-08-12
- Booksellers Suspect AI Firms Are Destroying Rare Books for Training Data — Ars Technica AI · 2026-08-12